Using immunotherapy to target EGF in patients with NSCLC.
Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland 20889, USA.
Deirdre
D
O'Mahony
Phillip A
PA
Dennis
D002289:Carcinoma, Non-Small-Cell Lung / Q000628:therapy*; D017321:Clinical Trials, Phase I as Topic; D004815:Epidermal Growth Factor / Q000276:immunology*; D005260:Female; D006801:Humans; D016233:Immunotherapy, Active; D008175:Lung Neoplasms / Q000628:therapy*; D008297:Male
D004815:Epidermal Growth Factor